James Hassard, Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 15,000 shares at $44.08 ($661K) on 2024-07-05, disclosed to the SEC on 2024-07-09.
Scheduled sale ($661k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARWR | SELL | 2021-01-08 | $1.2M | — | Filing → |